Literature DB >> 12233927

Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8).

Ronit Sarid1, Avraham Klepfish, Ami Schattner.   

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) is a recently discovered and characterized member of the herpesvirus family. It is one of a few viruses proved to be associated with tumorigenesis in humans. Its causal association with 4 clinical and epidemiologic variants of Kaposi sarcoma (classic, endemic, iatrogenic, and acquired immunodeficiency virus-associated) as well as with several lymphoproliferative disorders (notably primary effusion lymphoma and multicentric Castleman disease) is reviewed critically. Issues related to the epidemiology, transmission, and molecular and serologic diagnosis are discussed. Several intriguing oncogenic mechanisms of KSHV infection have been identified. These are often dependent on the interaction of KSHV with other viruses, such as human immunodeficiency virus, Epstein-Barr virus, or both. However, important problems remain and once resolved will substantially enhance our understanding of oncogenesis in general and viral-induced oncogenesis in particular. This may also translate into improved treatment and perhaps prevention of this common and intriguing viral infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12233927     DOI: 10.4065/77.9.941

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  16 in total

1.  Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.

Authors:  Yi Jin; Zhiheng He; Deguang Liang; Quanzhi Zhang; Hongxing Zhang; Qiang Deng; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Successful eradication of relapsed primary effusion lymphoma with high-dose chemotherapy and autologous stem cell transplantation in a patient seronegative for human immunodeficiency virus.

Authors:  Jong-Ho Won; Seung-Hyo Han; Sang-Byung Bae; Chan-Kyu Kim; Nam-Su Lee; Kyu-Taeg Lee; Sung-Kyu Park; Dae-Sik Hong; Dong-Wha Lee; Hee-Sook Park
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

3.  Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.

Authors:  Ke Lan; Daniel A Kuppers; Erle S Robertson
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 4.  Why do viruses cause cancer? Highlights of the first century of human tumour virology.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

5.  Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.

Authors:  Ke Lan; Daniel A Kuppers; Subhash C Verma; Nikhil Sharma; Masanao Murakami; Erle S Robertson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Parotid localized Castleman's disease and HHV-8 infection: a case report.

Authors:  Elisabetta Caselli; Davide Padovani; Roberto Di Carlo; Enrico Grandi; Monica Galvan; Enzo Cassai; Antonio Pastore
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-26       Impact factor: 2.503

7.  Immunohistochemical study association between human herpesvirus 8 and multiple myeloma.

Authors:  Mohammad Hadi Sadeghian; Mehrdad Katebi; Hossein Ayatollahi; Mohammad Reza Keramati
Journal:  Int J Hematol       Date:  2008-07-16       Impact factor: 2.490

8.  Treatment of Classic Kaposi's Sarcoma Showing a Discretely Scattered Distribution with Intralesional Vinblastine Injections.

Authors:  Bo Ri Kim; Jung Tae Park; Sang Young Byun; Soon Hyo Kwon; Chang Hun Huh
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

9.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.

Authors:  Ke Lan; Daniel A Kuppers; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Recurrent Kaposi sarcoma of the ear in an HIV-negative patient: A case report with review of the literature. Is ear a predilection site for Kaposi sarcoma in HIV-negatives?

Authors:  Ifa Etesami; Yasamin Kalantari; Alireza Ghanadan; Azadeh Rezayat
Journal:  Clin Case Rep       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.